- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03801330
Inspiration Point-A Digital Pulmonary Rehabilitation Tool Management Interventions
Inspiration Point-A Digital Pulmonary Rehabilitation Tool for Use With Self- Management Interventions
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28203
- Wake Forest Baptist Health
-
Durham, North Carolina, United States, 27705
- Duke University Healthcare
-
-
West Virginia
-
Dawes, West Virginia, United States, 25054
- Cabin Creek Health Systems Inc
-
Scarbro, West Virginia, United States, 25917
- New River Health Association
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants will have physician permission and diagnosis COPD (FEV1 >30%-80%),
- Gold level A-D, and
- Ability to perform the 6 Minute Walk Test (6MWT).
- This means that participants must meet the standard definition of COPD and have a post-bronchodilator measurement of FEV1/FVC < 0.7.
- All COPD Assessment Test scores will be accepted.
- Patients must have an mMRC score = 1-4.
- Additionally, patients must have taken a Pulmonary Function Test within 1 year or they must retake (for baseline measurement) before participating in the study.
- Patients must not have had a Pulmonary Rehabilitation class within the last 6 months.
- If participants have had a recent cardiac event within 6 months (such as a myocardial infarction or an abnormal cardiac catheterization) they must obtain cardiologist approval before participating in the study.
- In an effort to evaluate feasibility we will request that participants have their own Wi-Fi. Participants may use their own mobile device if they prefer but Blue Marble will have ample supply to provide to participants a device for the purposes of this study.
- Target representativeness for gender, based on COPD demography will be ~50% women, based on recent trends indicating that women have an equal, and perhaps slightly greater risk of COPD compared to men3.
- The Ethnicity/Race target recruitment, consistent with the US and the population at each site.
- Participants must speak, read, and understand English at or above the 6th-grade level (as indicated by having a driver's license or self-report of completion of some high school).
Exclusion Criteria for participants with COPD:
- Pulmonary functional fitness that precludes participation in outpatient/home PR program (i.e. requires in-patient supervision or severity of a co-morbidity that represents a contradiction to exercise in a self-directed program) will be exclusionary.
- A participant who desaturates below SaO2 <88% during the pre-test 6MWT and does not have personal oxygen available will be referred for further evaluation and can be included once they have an O2 titration and supplemental oxygen.
- Other exclusions include if a patient's oxygen use exceeds 4 liters per minute (LPM) or those who score less than 100 meters during the entry 6-minute walk distance.
- Participants with coronary problems will be excluded based on specific morbidity and severity. These coronary exclusions include coronary artery disease with unstable angina.
- Additional exclusions include: any respiratory disorder other than COPD that contraindicates participation in a home-based program.
- The inability to learn how to use Inspiration Point
- An acute neurological or cardiovascular condition such as stroke or acute heart surgery.
- Active cancer with an anticipated survival of less than 6 months or treatment that will preclude them from participating in Pulmonary Rehab.
- A participant with high fall risk as per physician determination.
- The presence of a neurologic disorder that precludes a potential participant from following a typical COPD exercise program or demonstrating hand function sufficient to interface with the tablet.
- This also includes patients with prior or current neurologic event/condition presenting fall risk or requiring assist device for ambulation will also be excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Usual Care
Participants in the Usual Care Pulmonary Rehabilitation will receive usual care pulmonary rehab program.
Usual care programs typically consist of exercises including upper extremity strengthening, lower extremity strengthening, aerobic exercises such as walking and balance training.
Each program is personalized as per the participant's ability.
The intervention is usual care exercise and education, which is personalized for each participant.
No drugs are being tested in this study.
|
Participants in the Usual Care Pulmonary Rehabilitation Program group will complete an 8 week clinic based Pulmonary Rehabilitation Program (usual care).
|
|
Experimental: Software Tool
Participants in the Pulmonary Rehabilitation Software-Based Home Program will use a digital software tool (APP) to obtain the pulmonary rehab home program.
Home programs typically consist of exercises including upper extremity strengthening, lower extremity strengthening, aerobic exercises such as walking and balance training.
Each program is personalized as per the participant's ability.
The intervention is exercise and education, which is personalized for each participant.
No drugs are being tested in this study.
|
Participants in the Pulmonary Rehabilitation Software-Based Home Program group will complete an 8-week home-based Pulmonary Rehabilitation Program using a software app (software)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
6 Minute Walk Test
Time Frame: Change from baseline 6 Minute Walk Test score at 2 months
|
Measures distance walked in 6 minutes
|
Change from baseline 6 Minute Walk Test score at 2 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Modified Medical Research Council Dyspnea Scale (mMRC)
Time Frame: Change from baseline Modified Medical Research Council Dyspnea Scale (mMRC) score at 2 months
|
Single question questionnaire describing shortness of breath.
Total Score Range from 0-4, 0 is better.
|
Change from baseline Modified Medical Research Council Dyspnea Scale (mMRC) score at 2 months
|
|
Medical Outcomes Scale VR-12
Time Frame: Change from baseline VR-12 score at 2 months
|
Survey of health status and quality of life From (https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form/scoring.html) "Scoring the RAND 36-Item Health Survey is a two-step process. First, precoded numeric values are recoded per the scoring key given in Table 1. Note that all items are scored so that a high score defines a more favorable health state. In addition, each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively. Scores represent the percentage of total possible score achieved. In step 2, items in the same scale are averaged together to create the 8 scale scores. Table 2 lists the items averaged together to create each scale. Items that are left blank (missing data) are not taken into account when calculating the scale scores. Hence, scale scores represent the average for all items in the scale that the respondent answered." |
Change from baseline VR-12 score at 2 months
|
|
St Georges Respiratory Questionnaire (SGRQ)
Time Frame: Change from baseline St Georges Questionnaire score at 2 months
|
A self-administered disease-specific instrument designed to measure the impact on overall health, daily life, and perceived well-being in patients with obstructive airways disease. The questionnaire has 50 items Scores range from 0-100, with higher scores indicating more limitations https://www.thoracic.org/members/assemblies/assemblies/srn/questionaires/sgrq.php |
Change from baseline St Georges Questionnaire score at 2 months
|
|
Lung Information Needs Questionnaire (LINQ)
Time Frame: Change from baseline Lung Information Needs Questionnaire score at 2 months
|
The questionnaire used to identify a person with COPD's need for information about their disease. The questionnaire measures the extent to which the patient needs more information, as perceived by the patient and clinician. It is scored to produce an overall score and 6 domain scores (Disease knowledge, medicines, self-management, exercise, diet, smoking). The score is the sum of all 6 domains with a range from 0-25. High scores indicate high information needs, a lower score is better. |
Change from baseline Lung Information Needs Questionnaire score at 2 months
|
|
Software Usability Scale (SUS)
Time Frame: Change from baseline Software Usability Scale (SUS)score at 2 months
|
Measures usability and learnability of software tools.
Total Score provides percentile score indicating usability/learnability.
Range 0-100, Higher (100%) is better.
|
Change from baseline Software Usability Scale (SUS)score at 2 months
|
|
Timed Up and Go Test (TUG)
Time Frame: Change from baseline TUG score at 2 months
|
Measures the time taken to stand up from a chair, walk 10 feet, turn around, and return to sitting.
|
Change from baseline TUG score at 2 months
|
|
30 Second Sit to Stand Test (30STST)
Time Frame: Change from baseline 30STST score at 2 months
|
Measures the number of times a participant can stand from a seated position in 30 seconds
|
Change from baseline 30STST score at 2 months
|
|
4 Stage Balance Test (4SBT)
Time Frame: Change in 4STBT score at 2 months
|
Measures balance in 4 increasing more challenging positions
|
Change in 4STBT score at 2 months
|
|
COPD Assessment Test (CAT)
Time Frame: Change in CAT score at 2 months
|
An 8 item test which measures the effect of COPD on a patient's overall health.
The items on this test measure a patient's cough, sputum, breathlessness, chest tightness, confidence, activity, sleep and energy levels
|
Change in CAT score at 2 months
|
|
Depression Screen (DS)
Time Frame: Change in DS score at 2 months
|
A 2 question survey which can be used to evaluate your risk of depression
|
Change in DS score at 2 months
|
|
Charlson Index (CCI)
Time Frame: Change in CCI score at 2 months
|
The Charlson comorbidity index predicts the one-year mortality for a patient who may have a range of comorbid conditions, such as heart disease or cancer (a total of 22 conditions).
This index is helpful to ensure the groups are equal for the study comparison and statistics.
|
Change in CCI score at 2 months
|
|
Fall Risk Questionnaire (FRQ)
Time Frame: Change in FRQ score at 2 months
|
The FRQ is comprised of 13 questions about a person's history of falls and potential fall risk.
|
Change in FRQ score at 2 months
|
|
Positive Affect and Well-Being Short Form (PROMIS)
Time Frame: Change in PROMIS score at 2 months
|
This test is a health-related quality of life questionnaire.
|
Change in PROMIS score at 2 months
|
|
Single Item Literacy Screener (SILS)
Time Frame: Change in SILS score at 2 months
|
The SILS is a single item survey which determines literacy and health literacy.
It is a direct assessment of a patient's need for assistance in reading health materials.
|
Change in SILS score at 2 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Sheryl Flynn, PT PhD, Blue Marble Health
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HL137502
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COPD
-
University Medical Center GroningenCompleted
-
Ryme Medical, Inc.Not yet recruitingCOPD | Lung Disease, Chronic Obstructive | COPD Patients | COPD Acute Exacerbation | COPD (Chronic Obstructive Pulmonary Disease) | Lung Disease Airways | COPD Exacerbations
-
Insel Gruppe AG, University Hospital BernUniversity Hospital, Geneva; Cantonal Hospital St. Gallen, SwitzerlandNot yet recruiting
-
Istituto Nazionale di Ricovero e Cura per AnzianiRecruiting
-
Bio-Sensing Solutions S.L. (DyCare)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Centre...Recruiting
-
Sir Run Run Shaw HospitalRecruiting
-
The First Affiliated Hospital of Guangzhou Medical...Recruiting
-
Association des Réseaux BronchioliteLaboratoire Système et Matériaux pour la Mécatronique (SYMME)Recruiting
-
Polytechnic Institute of PortoNippon Gases PortugalRecruiting
-
China-Japan Friendship HospitalNot yet recruiting
Clinical Trials on Usual Care Pulmonary Rehabilitation Program
-
Fundación Pública Andaluza para la gestión de la...Unknown
-
University of Erlangen-NürnbergBad Reichenhall Clinic, Center for Rehabilitation, Pulmonology and Orthopedics...CompletedPulmonary Disease, Chronic ObstructiveGermany
-
NHS Greater Glasgow and ClydeUnknownAsthmaUnited Kingdom
-
Aveiro UniversityFundação para a Ciência e a TecnologiaCompletedChronic Obstructive Pulmonary Disease (COPD)Portugal
-
Queen's UniversityCompletedChronic Obstructive Pulmonary DiseaseCanada
-
University of AlbertaUniversity of CalgaryCompletedChronic Obstructive Pulmonary Disease (COPD)Canada
-
Imperial College Healthcare NHS TrustRoyal Brompton & Harefield NHS Foundation Trust; London Cancer Alliance (North...CompletedLung Cancer | Pulmonary Rehabilitation | LobectomyUnited Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)CompletedEmphysema | Lung Cancer | COPD | Chronic Obstructive Lung DiseaseUnited States
-
Case Comprehensive Cancer CenterUnited States Department of DefenseRecruitingLung Cancer | Non-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage IVUnited States
-
Radboud University Medical CenterPrincess Beatrix Muscle FoundationCompletedParsonage Turner Syndrome | Neuralgic Amyotrophy | Neuralgic Amyotrophy, Hereditary | Brachial NeuritisNetherlands